{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:19:35Z","timestamp":1789269575934,"version":"build-2803163510"},"reference-count":25,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>Treatment for breast cancer (BC) can lead to debilitating symptoms that can reduce outcomes and quality of life (QoL). Symptom surveillance using a remote symptom monitoring (RSM) platform enables the capture and reporting of patient-reported outcomes (PROs) from home. Women with BC used an RSM platform to complete weekly surveys and report any symptoms experienced during treatment. Symptoms reported as moderate\/severe generated alerts to the clinical team. Clinical actions in response to the alert were captured. Results highlighted the value of data generated from a PRO-generated alert system to characterize longitudinal symptom burden and QoL in real-world BC practice, particularly in patients with poor functional status. The most prevalent symptoms that resulted in alerts were pain, nausea\/vomiting, neuropathy, fatigue, and constipation. Most women reported one or more moderate\/severe symptoms that generated an alert with an average of two alerts per week. Patients with frail status had more alerts, worse QoL and higher treatment bother, indicating that frail patients may benefit from continuous monitoring of symptoms, function, and QoL over time. A case study of patients without pre-existing peripheral neuropathy showed the rapid trajectory from the first report of mild neuropathy until alerts were generated, making a case for early intervention.<\/jats:p>","DOI":"10.3390\/bioengineering11080846","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T07:37:21Z","timestamp":1724053041000},"page":"846","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Remote Symptom Alerts and Patient-Reported Outcomes (PROS) in Real-World Breast Cancer Practice: Innovative Data to Derive Symptom Burden and Quality of Life"],"prefix":"10.3390","volume":"11","author":[{"given":"Emelly","family":"Rusli","sequence":"first","affiliation":[{"name":"Carevive by HealthCatalyst, Boston, MA 02110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Wujcik","sequence":"additional","affiliation":[{"name":"Carevive by HealthCatalyst, Boston, MA 02110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Galaznik","sequence":"additional","affiliation":[{"name":"Carevive by HealthCatalyst, Boston, MA 02110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00520-016-3417-6","article-title":"Quality of life (QOL) and symptom burden (SB) in patients with breast cancer","volume":"25","author":"Hamer","year":"2017","journal-title":"Support. Care Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/CCI.20.00081","article-title":"Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: Findings from the PRO-TECT trial","volume":"4","author":"Basch","year":"2020","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejso.2019.08.011","article-title":"Addressing frailty in patients with breast cancer: A review of the literature","volume":"46","author":"Jauhari","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e10875","DOI":"10.2196\/10875","article-title":"Electronic systems for patients to report and manage side effects of cancer treatment: Systematic review","volume":"21","author":"Warrington","year":"2019","journal-title":"J. Med. Internet Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1002\/cam4.4202","article-title":"Prevalence and predictors of peripheral neuropathy after breast cancer treatment","volume":"10","author":"Kamgar","year":"2021","journal-title":"Cancer Med."},{"key":"ref_8","first-page":"djx162","article-title":"Long-term peripheral neuropathy in breast cancer patients treated with adjuvant chemotherapy: NRG Oncology\/NSABP B-30","volume":"110","author":"Bandos","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10549-020-06079-2","article-title":"Characterization of chemotherapy-induced peripheral neuropathy using patient reported outcomes and quantitative sensory testing","volume":"186","author":"Zhi","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_10","unstructured":"National Cancer Institute (2024, June 27). Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE\u00ae), Available online: https:\/\/healthcaredelivery.cancer.gov\/pro-ctcae\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0959-8049(01)00448-8","article-title":"EORTC Quality of Life Group; Quality of Life Unit; European Organisation for Research and Treatment of Cancer. Quality of life research within the EORTC\u2014The EORTC QLQ-C30","volume":"38","author":"Fayers","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s11136-015-0992-9","article-title":"Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients","volume":"24","author":"Jensen","year":"2015","journal-title":"Qual. Life Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cncr.31133","article-title":"Validity and usefulness of a single-item measure of patient-reported bother from side effects of cancer therapy","volume":"124","author":"Pearman","year":"2018","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1740774520975120","article-title":"Composite grading algorithm for the National Cancer Institute\u2019s Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"18","author":"Basch","year":"2021","journal-title":"Clin. Trials"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: An International Myeloma Working Group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005650-199601000-00006","article-title":"Can comorbidity be measured by questionnaire rather than medical record review?","volume":"34","author":"Katz","year":"1996","journal-title":"Med. Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cncr.21422","article-title":"Developing a cancer-specific geriatric assessment","volume":"104","author":"Hurria","year":"2005","journal-title":"Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","article-title":"Frailty in relation to the accumulation of deficits","volume":"62","author":"Rockwood","year":"2007","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Searle, S.D., Mitnitski, A., Gahbauer, E.A., Gill, T.M., and Rockwood, K. (2008). A standard procedure for creating a frailty index. BMC Geriatr., 8.","DOI":"10.1186\/1471-2318-8-24"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1200\/JCO.2009.27.1916","article-title":"Prognostic factors in patients with advanced cancer: Use of the patient-generated subjective global assessment in survival prediction","volume":"28","author":"Martin","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e230157","DOI":"10.57264\/cer-2023-0157","article-title":"Implementation of electronic patient-reported outcomes for symptom monitoring during cancer treatment: The importance of getting it right","volume":"12","author":"Basch","year":"2023","journal-title":"J. Comp. Eff. Res."},{"key":"ref_23","first-page":"e15994","article-title":"Pain management in breast cancer patients: A multidisciplinary approach","volume":"13","author":"Alhazmi","year":"2021","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cam4.3794","article-title":"Symptom clusters experienced by breast cancer patients at various treatment stages: A systematic review","volume":"10","author":"So","year":"2021","journal-title":"Cancer Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jpainsymman.2017.04.011","article-title":"Neuropathic pain after breast cancer treatment: Characterization and risk factors","volume":"54","author":"Pereira","year":"2017","journal-title":"J. Pain Sym. Manag."}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/11\/8\/846\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:38:59Z","timestamp":1760110739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/11\/8\/846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["bioengineering11080846"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering11080846","relation":{},"ISSN":["2306-5354"],"issn-type":[{"value":"2306-5354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]}}}